fluorouracil has been researched along with picibanil in 107 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 66 (61.68) | 18.7374 |
| 1990's | 27 (25.23) | 18.2507 |
| 2000's | 12 (11.21) | 29.6817 |
| 2010's | 1 (0.93) | 24.3611 |
| 2020's | 1 (0.93) | 2.80 |
| Authors | Studies |
|---|---|
| Hamai, Y; Hattori, T; Ikeda, T; Nagusa, Y; Nakano, A; Takiyama, W | 1 |
| Misawa, S; Ohkuma, S; Sawai, K; Sonoda, Y; Takino, T | 1 |
| Fujimoto, S; Ishigami, H; Itoh, K; Minami, T; Miyazaki, M; Takahashi, M | 1 |
| Abe, T; Kawai, K; Masuda, M; Misawa, S; Sawai, K; Takino, T | 1 |
| Furusawa, M; Gojobori, M; Mashiba, H; Matsunaga, K; Yoshinaga, H | 1 |
| Hattori, T; Ikeda, H; Niimoto, M; Toge, T; Yamada, Y | 1 |
| Kikuchi, K; Komatsu, Y; Nishimura, S; Sakata, Y; Sugawara, K; Yoshida, Y | 2 |
| Hashimoto, S; Kihara, K; Miura, Y; Morita, N; Nagai, T; Nakao, Y; Shimokawahara, H; Shingami, T; Shiwaku, Y; Tomomatsu, H; Yunoki, K | 1 |
| Harada, T; Hattori, T; Ikeda, H; Niimoto, M; Toge, T; Yamagata, S | 1 |
| Fukushima, M; Ishikawa, Y; Ishioka, T; Kakuta, H; Kikuchi, A; Machida, S; Nishikawa, T; Takashima, K | 1 |
| Wakui, A | 1 |
| Ando, T; Iesato, H; Kobayashi, J; Miyamoto, Y; Morishita, Y; Owada, S; Saito, A; Takeyoshi, I; Taniguchi, T; Yokomori, T | 1 |
| Gotoh, M; Kanai, T; Monden, M; Monden, T; Mori, T; Sakon, M; Shimizu, J; Tarui, T; Tomoda, K; Umeshita, K | 1 |
| Kim, JP; Kwon, OJ; Oh, ST; Yang, HK | 1 |
| Fujimoto, I; Hasumi, K; Masubuchi, K; Shimizu, Y; Tatsuki, Y; Yamauchi, K | 1 |
| Iwasaki, K; Sato, S; Torisu, M | 1 |
| Hamano, K; Imai, S; Kirita, T; Mabuchi, G; Oishi, H; Seshimo, A; Yamada, Y; Yoneyama, K | 1 |
| Akagi, M; Kakegawa, T; Maehara, Y; Shimazu, H; Sugimachi, K; Tomita, M | 1 |
| Hiraoka, T; Miyauchi, Y; Mizutani, J; Yamashita, R | 1 |
| Hayashi, H; Hazama, S; Murakami, T; Oka, M; Suzuki, T | 1 |
| Iwanari, O; Kitao, M; Miyako, J; Moriyama, M; Nakayama, S; Ryuko, K | 1 |
| Niitsu, Y; Saito, K; Sato, M; Takagane, A; Terashima, M; Yokkaichi, H | 1 |
| Goshima, H; Ishida, N; Itou, F; Kokehara, N; Matsumoto, M; Oota, M; Yamazaki, Y | 1 |
| Ichihashi, H; Imaizumi, M; Kamei, H; Kondo, T | 2 |
| Handa, Y; Hayashi, M; Ishikura, A; Itoh, H; Kabuto, M; Kawano, H; Kobayashi, H; Kubota, T; Yamamoto, S; Yamashima, T | 1 |
| Koda, A; Mihara, M; Mori, H; Sakamoto, O; Teshima, K; Uesugi, U; Xu, Q | 1 |
| Abe, O; Hattori, T; Kikuchi, K; Komi, N; Kondo, T; Kunii, Y; Nakajima, T; Nakazato, H; Taguchi, T; Tanabe, T | 1 |
| Hosoi, H; Kitagawa, M; Sinmyo, K; Susaki, H; Suwa, H; Yamaguchi, K | 1 |
| Hamada, H; Mori, N; Nakajima, I; Nakamura, T; Nakamura, Y; Tanaka, A; Wada, T; Yasutomi, M | 1 |
| Fujise, K; Hasumura, S; Homma, S; Kameda, H; Matsuura, T; Nagamori, S; Niiya, M; Shimizu, K; Sujino, H | 1 |
| Fukuda, I; Hurukawa, H; Imaoka, S; Ishikawa, O; Kabuto, T; Nagano, H; Ohigashi, H; Sasaki, Y; Shibata, T; Wada, H | 1 |
| Itoh, T; Komatsu, Y; Saitoh, S; Sakata, Y; Sasaki, D; Suzuki, H; Takagi, S; Tsushima, K; Yoshida, Y | 1 |
| Hori, T; Kan, N; Mise, K; Nakanishi, M; Ohgaki, K; Okino, T; Sato, K; Teramura, Y; Tobe, T; Yamasaki, S | 1 |
| Fujiwara, A; Katsube, Y; Myoga, H; Nogawa, T; Ohta, S; Shigemasa, K; Shinko, Y; Tamaki, M | 1 |
| Hashizume, Y; Ichihashi, T; Iida, S; Kimoto, H; Kobayashi, H; Sato, H; Shimizu, J; Tsunamura, Y; Watanabe, Y; Yamada, T | 1 |
| Fujitomi, Y; Ichimanda, M; Mori, Y; Oka, K; Shibata, O; Shigemitsu, O; Shirabe, J; Takasaki, H; Uchida, Y | 1 |
| Nakazawa, S; Okamura, S; Yamao, K; Yoshino, J | 1 |
| Kim, JP | 2 |
| Kato, T; Kito, T; Miyaishi, S; Morimoto, T; Nakazato, H; Nishimura, M; Sakamoto, J; Yamamura, Y; Yasue, M; Yasui, K | 1 |
| Yasutomi, M | 1 |
| Nakamura, A; Ohkawa, T; Okamoto, Y | 1 |
| Abe, T; Horiike, S; Inazawa, J; Misawa, S; Nishigaki, H; Okuda, T; Taniwaki, M; Tsuji, H; Yashige, H; Yokota, S | 1 |
| Abe, M; Amano, T; Imada, T; Matsumoto, A; Tamura, S; Yamamoto, Y | 1 |
| Baba, T; Furukohori, N; Itoh, T; Kawata, K; Kimura, T; Munakata, A; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y | 1 |
| Fukushi, G; Itoh, T; Kimura, M; Kimura, T; Kishibe, T; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y; Tsushima, K | 1 |
| Hatano, T; Hayakawa, M; Igarashi, M; Kashiwabara, N; Koyama, Y; Miyazato, T; Osawa, A; Saito, S; Sato, K | 1 |
| Harada, Y; Hirakawa, K; Nakata, M; Okazaki, H; Sera, K; Suzuki, M; Tagashira, N; Takebayashi, S; Yajin, K; Yashiki, T | 1 |
| Asaishi, K; Hayasaka, H; Okazaki, M | 1 |
| Furukawa, M; Kusano, T; Lin, Y; Miyazaki, K; Nakata, T; Setoguchi, M; Suga, K; Tachibana, K; Tashiro, K | 1 |
| Maeda, C; Muto, T; Nashimoto, A; Sasaki, K | 1 |
| Akimoto, M; Kasai, M; Nishihira, T | 1 |
| Hatta, M; Hirakawa, T; Kito, T; Kobari, T; Nakazato, H; Yamamura, Y; Yasue, M | 1 |
| Ariga, T; Kikuchi, T; Koh, Z; Mukai, M; Nagao, K; Nagashima, T; Odaka, M; Ryu, S; Satoh, H; Yamazaki, Y | 1 |
| Endoh, F; Fujimoto, S; Kawata, S; Kurihara, M; Miyazaki, M; Ohta, M; Shimura, T; Sugasawa, H; Takahashi, O; Udagawa, I | 1 |
| Arai, T; Honda, M; Kanbe, K; Kaneko, K; Maeda, S; Mukae, K; Murahashi, I; Sakuma, H; Tabata, Y; Takasaki, E | 1 |
| Nakazato, H; Ota, K; Yamamura, Y; Yasue, M | 1 |
| Fujiwara, M; Futatsuki, K; Ishibashi, I; Izuno, O; Kanda, Y; Shimada, S; Suda, Y; Takayama, S; Takemori, Y; Takubo, K | 1 |
| Akiharu, W; Fujiwara, M; Higashi, T; Ito, T; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Shiota, T; Yamamoto, H; Yamauchi, Y | 1 |
| Murakami, M; Nakazato, H; Ota, K; Suchi, T; Yasue, M | 1 |
| Asari, S; Doi, A; Fujiwara, T; Furuta, T; Matsumoto, K; Moriya, Y; Nakasone, S; Nishimoto, A; Ohnishi, R; Tabuchi, K | 1 |
| Abe, R; Akimoto, M; Ewasaki, H; Kasai, M; Matano, S; Nakajima, Y; Ueki, H | 1 |
| Abe, J; Hirai, Y; Iwasaki, T; Kato, K; Kishimoto, H; Koga, S; Maeta, K; Maeta, M; Masaki, T; Osaki, Y; Shimizu, N; Sugihara, T; Tasaki, M; Watanabe, S; Yamashiro, N | 1 |
| Kishimoto, H; Koga, S; Maeta, M; Masaki, T; Oda, M; Shimizu, N; Tanida, O; Watnabe, S; Yamane, T; Yoshida, Y | 1 |
| Asaoka, K; Horiuchi, M; Inuyama, Y; Kohno, N; Mashino, S; Ozu, R | 1 |
| Takada, M | 1 |
| Kito, T; Nakazato, H; Yamada, E; Yamamura, Y; Yasue, M | 1 |
| Izumi, T; Kurihara, M; Maruyama, T; Miyasaka, K; Sasaki, Y | 1 |
| Nakazato, H | 1 |
| Amano, H; Hiura, T; Mukai, M; Nagao, K; Nakajima, K; Namiki, S; Oda, S; Yamazaki, Y | 1 |
| Izumi, T; Kurihara, M; Maruyama, T; Sasaki, Y; Shirakabe, H | 1 |
| Honda, M; Kanbe, K; Kaneko, K; Maeda, S; Murahashi, I; Takahashi, E | 1 |
| Kozłowicz-Gudzińska, I; Porwit-Ksiazek, A; Zborzil, J | 1 |
| Den, N; Mukai, M; Nagao, K; Namiki, S; Oda, S; Yamazaki, Y | 1 |
| Hiura, T; Mukai, M; Nagao, K; Namiki, S; Yamazaki, Y | 1 |
| Abe, R; Akimoto, M; Kasai, M | 1 |
| Henmi, K; Kikuchi, S; Nakamoto, K; Nio, Y; Tanaka, A | 1 |
| Akiyama, T; Kiriyama, M; Kita, I; Kosaka, T; Kurosaka, Y; Matsushita, M; Takashima, S; Tomita, F | 1 |
| Aoyagi, K; Kawabata, S; Kodama, I; Koufuji, K; Kumegawa, H; Maruiwa, M; Ohta, J; Suematsu, T; Tanaka, T; Tsuji, Y | 1 |
| Fukuda, S; Moriya, N; Sakata, Y; Sasaki, D; Suto, T; Watanabe, Y; Yoshida, Y | 1 |
| Hata, Y; Inoue, T; Konno, T; Nakanishi, M; Ogita, M; Ohira, S; Sasaki, F; Taguchi, K; Takahashi, H; Uchino, J | 1 |
| Baba, S; Itaya, S; Kobayashi, T; Matsuda, T; Motai, H; Shimada, J; Suzuki, K; Tsuge, I | 1 |
| Azuma, S; Furuta, T; Kato, M; Kida, H; Kunieda, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Umemoto, T | 1 |
| Harada, T; Ichinose, Y; Imamura, M; Kan, N; Kodama, H; Li, L; Moriguchi, Y; Sato, K; Sugie, T | 1 |
| Furukawa, T; Hoffman, RM; Kitajima, M; Kubota, T; Kuo, TH; Watanabe, M | 1 |
| Inutsuka, K; Maruiwa, M; Noutomi, M; Ohta, J; Tokuhara, K | 1 |
| Fujisawa, J; Kondo, Y; Miyakawa, K; Nakanishi, Y; Nishimura, A; Oku, T; Osawa, S; Shiroto, H; Uchino, J | 1 |
| Fukada, D; Kato, M; Kawai, M; Kunieda, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Umemoto, T | 1 |
| Itoh, S; Watanabe, T | 1 |
| Adachi, T; Fukada, D; Kato, M; Kawaguchi, Y; Kunieda, K; Miya, K; Nagao, N; Saji, S; Sugiyama, Y; Takagi, Y; Takao, H; Umemoto, T | 1 |
| Cho, KS; Choi, YM; Kim, SY; Park, HC; Yoon, C; Yoon, HJ | 1 |
| Amano, M; Haba, A; Monden, M; Monden, T; Ohue, M; Sakita, I; Sekimoto, M; Tamaki, Y; Tomita, N | 1 |
| Chijiiwa, K; Kuroiwa, T; Morisaki, T; Nakamura, K; Noshiro, H; Ogawa, T; Tanaka, M; Uchiyama, A; Yamanaka, N | 1 |
| Aoyagi, K; Koufuji, K; Murakami, N; Shirouzu, K; Takeda, J; Terasaki, Y; Yamasaki, Y; Yano, S | 1 |
| Ariki, N; Funaki, M; Gouchi, A; Iwagaki, H; Morimoto, Y; Shimamura, H; Tanaka, N | 1 |
| Begum, NM; Fujimori, T; Hino, S; Hoque, MO; Kawamata, H; Nakashiro, KI; Omotehara, F; Sato, M; Shinagawa, Y; Uchida, D; Yoshida, H | 1 |
| Honda, S; Kawaguchi, Y; Kimura, A; Kunieda, K; Matsui, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H | 1 |
| Cho, YK; Choi, JH; Joo, HJ; Kim, HC; Kim, HS; Kim, MW; Lee, KB; Lim, HY; Yi, JW | 1 |
| Inagi, K; Makoshi, T; Nagai, H; Nakayama, M; Okamoto, M; Takahashi, H; Yao, K | 1 |
| Kawaguchi, Y; Saji, S; Sugiyama, Y | 1 |
| Hojyo, K; Isomoto, H; Kato, T; Kodaira, S; Kunii, Y; Kunitomo, K; Niimoto, M; Nishida, O; Ohashi, Y; Takahashi, T; Tominaga, T; Watanabe, M; Yasutomi, M | 1 |
| Hamada, T; Ichimura, W; Minagawa, N; Mino, K; Naito, H; Orimo, T; Shibazaki, W; Shinohara, T | 1 |
| Ahmed, SU; Kan, S; Okamoto, M; Oshikawa, T; Sasai, A; Sato, M; Tano, T | 1 |
| Bando, T; Fujita, T; Goda, H; Hamakawa, H; Homma, S; Kan, S; Kawakami, Y; Koido, S; Nakashiro, K; Okamoto, M; Sato, M; Shimodaira, S; Tano, T; Yamashita, N | 1 |
| Abe, S; Tanaka, M | 1 |
26 trial(s) available for fluorouracil and picibanil
| Article | Year |
|---|---|
Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer.
Topics: Anastomosis, Surgical; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Gastrectomy; Humans; Immunotherapy; Jejunostomy; Leukocyte Count; Male; Middle Aged; Mitomycin; Neoplasm Staging; Picibanil; Prognosis; Skin Tests; Stomach Neoplasms; Survival Rate; T-Lymphocytes | 1992 |
Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Picibanil; Prospective Studies; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supp
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Gastrectomy; Humans; Japan; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Picibanil; Prognosis; Proportional Hazards Models; Prospective Studies; Proteoglycans; Stomach Neoplasms; Survival Rate | 1990 |
[Adjuvant chemotherapy for gastric cancer--the third study. First report: central randomization by telephone method and analysis of patients' background factors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Fluorouracil; Humans; Japan; Mitomycin; Mitomycins; Multicenter Studies as Topic; Picibanil; Random Allocation; Stomach Neoplasms; Tegafur; Telephone | 1989 |
Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/OK-432 (MQ-F-OK) therapy and mitomycin C/5-fluorouracil/doxorubicin (FAM) therapy against advanced liver cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Clinical Trials as Topic; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Random Allocation | 1989 |
[Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carbazilquinone; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Picibanil; Pneumonectomy; Postoperative Care; Random Allocation | 1985 |
Clinical efficacy of endoscopic injections of OK-432 in the treatment of gastric cancer.
Topics: Administration, Oral; Administration, Topical; Aged; Biological Products; Clinical Trials as Topic; Female; Fluorouracil; Gastroscopy; Humans; Injections, Intradermal; Injections, Intravenous; Male; Middle Aged; Picibanil; Prognosis; Random Allocation; Stomach Neoplasms | 1988 |
Immunochemosurgery as a new approach to reasonable treatment of advanced cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Korea; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Random Allocation; Semustine; Stomach Neoplasms; T-Lymphocytes; Time Factors | 1988 |
[A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modality Therapy; Female; Fluorouracil; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Postoperative Period; Random Allocation; Stomach Neoplasms | 1986 |
[Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Clinical Trials as Topic; Double-Blind Method; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Clinical study on the effect of adjuvant immunochemotherapy using OK-432 and 5-FU in pharyngeal and laryngeal cancers].
Topics: Administration, Oral; Aged; Biological Products; Clinical Trials as Topic; Drug Administration Schedule; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Pharyngeal Neoplasms; Picibanil; Random Allocation | 1988 |
[Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
Topics: Animals; Combined Modality Therapy; Endocrine Glands; Female; Fluorouracil; Humans; Lentinan; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasms; Neoplasms, Experimental; Nutritional Physiological Phenomena; Picibanil; Stomach Neoplasms | 1986 |
[A controlled study of surgical adjuvant chemoimmunotherapy with FT-207 and OK-432 for advanced stomach cancer: the fourth study].
Topics: Administration, Oral; Aged; Biological Products; Clinical Trials as Topic; Combined Modality Therapy; Female; Fluorouracil; Gastrectomy; Humans; Injections, Subcutaneous; Male; Middle Aged; Picibanil; Postoperative Care; Prospective Studies; Random Allocation; Stomach Neoplasms; Tegafur | 1985 |
A controlled study of maintenance chemoimmunotherapy vs immunotherapy alone immediately following palliative gastrectomy and induction chemoimmunotherapy for advanced gastric cancer. Tokai cooperative study group for adjuvant chemoimmunotherapy of stomach
Topics: Antineoplastic Agents; Biological Products; Cytarabine; Drug Therapy, Combination; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Mitomycins; Palliative Care; Picibanil; Random Allocation; Stomach Neoplasms | 1981 |
Clinical trials with oral Futraful (INN: Tegafur) in cancer of the head and neck.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Picibanil; Proteoglycans; Tegafur | 1981 |
[Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer].
Topics: Aged; Biological Products; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms | 1983 |
[Cooperative studies on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Picibanil; Postoperative Care; Proteoglycans; Stomach Neoplasms | 1984 |
[Immunological approach and surgical treatment of cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Gastrectomy; Humans; Mitomycin; Mitomycins; Picibanil; Prospective Studies; Stomach Neoplasms; Tegafur | 1983 |
[Evaluation of Picibanil as an adjuvant chemotherapeutic agent].
Topics: Adjuvants, Immunologic; Adult; Aged; Biological Products; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Picibanil; Vincristine | 1982 |
Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Embolization, Therapeutic; Ethanol; Female; Fluorouracil; Humans; Immunologic Factors; Lentinan; Liver Neoplasms; Male; Middle Aged; Picibanil; Survival Rate | 1994 |
[Combination therapy with low dose adriamycin for advanced or recurrent breast cancer. Hokkaido Breast Cancer Treatment Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Picibanil; Survival Rate; Tamoxifen; Treatment Outcome | 1993 |
[Randomized controlled study on adjuvant immunochemotherapy with carmofur (HCFU) for noncuratively resected and unresected gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Combined Modality Therapy; Fluorouracil; Follow-Up Studies; Humans; Immunotherapy; Japan; Mitomycin; Picibanil; Stomach Neoplasms | 1996 |
[Clinical evaluation of intermittent hepatic arterial infusion therapy for metastatic liver tumor of gastric and colorectal cancer].
Topics: Adenocarcinoma, Papillary; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Hepatic Artery; Humans; Immunotherapy; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Interleukin-2; Leucovorin; Liver Neoplasms; Male; Middle Aged; Picibanil; Recombinant Proteins; Stomach Neoplasms | 1998 |
OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinoma: a randomized Phase III trial.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Immunotherapy; Male; Middle Aged; Mitomycin; Picibanil; Stomach Neoplasms | 1998 |
Selective augmentations of intratumoral 5-fluorouracil concentration by local immunotherapy with OK-432 and fibrinogen.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; Colon; Colorectal Neoplasms; Combined Modality Therapy; Drug Synergism; Female; Fibrinogen; Floxuridine; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Picibanil; Rectum | 2000 |
Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-flu
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Injections, Subcutaneous; Male; Middle Aged; Mitomycin; Neoplasm Staging; Picibanil; Pyrimidines; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2004 |
81 other study(ies) available for fluorouracil and picibanil
| Article | Year |
|---|---|
Combined treatment with by-pass operation, irradiation and immunochemotherapy for advanced thoracic esophageal cancer.
Topics: Adult; Aged; Bleomycin; Drug Therapy, Combination; Esophageal Neoplasms; Esophagoplasty; Fluorouracil; Humans; Immunotherapy; Middle Aged; Mitomycins; Picibanil; Prognosis; Skin Tests | 1979 |
[A combined immuno-chemotherapy with futraful and picibanil for advanced cancer (author's transl)].
Topics: Aged; Biological Products; Drug Therapy, Combination; Female; Fluorouracil; Humans; Intestinal Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Pancreatic Neoplasms; Picibanil; Stomach Neoplasms; Tegafur | 1977 |
Clinical value of immunochemotherapy with OK-432 or PS-K for stomach cancer patients.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Biological Products; Dinitrochlorobenzene; Drug Therapy, Combination; Fluorouracil; Humans; Immunotherapy; Lymphocyte Activation; Middle Aged; Phytohemagglutinins; Picibanil; Proteoglycans; Skin Tests; Stomach Neoplasms | 1979 |
Clinical studies on the combined immunochemotherapy with a streptococcal preparation (Picibanil) and other anticancer drugs.
Topics: Antineoplastic Agents; Biological Products; Carbazilquinone; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; Mitomycins; Neoplasms; Picibanil | 1979 |
Effect of immunochemotherapy on lymphocyte response of patients with gastrointestinal cancer.
Topics: Biological Products; Cytotoxicity Tests, Immunologic; Fluorouracil; Gastrointestinal Neoplasms; Humans; Immunotherapy; Lymphocyte Activation; Lymphocytes; Phytohemagglutinins; Picibanil | 1979 |
Correlation between lymphocyte responsiveness to mitogens and results of chemo-immunotherapy in patients with advanced cancer.
Topics: Adult; Aged; Biological Products; Female; Fluorouracil; Humans; Immunotherapy; Lymphocyte Activation; Male; Middle Aged; Mitomycins; Neoplasms; Phytohemagglutinins; Picibanil; Pokeweed Mitogens | 1979 |
[Combination chemotherapy of mitomycin-C, carboquone, 5-fluorouracil and OK-432 for inoperable gastric cancer (author's transl)].
Topics: Aged; Antineoplastic Agents; Carbazilquinone; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycins; Picibanil; Stomach Neoplasms | 1979 |
[A case with gastric cancer by OK-MF'C therapy (author's transl)].
Topics: Adenocarcinoma; Antineoplastic Agents; Cytarabine; Drug Therapy, Combination; Fluorouracil; Humans; Male; Middle Aged; Mitomycins; Myocardial Infarction; Picibanil; Stomach Neoplasms | 1979 |
Evaluation of chemotherapeutic effects on gastric cancer in relation to the histological pattern.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Cytarabine; Drug Therapy, Combination; Fluorouracil; Humans; Hyperplasia; Lymph Nodes; Lymphangitis; Lymphocytes; Mitomycins; Picibanil; Stomach Neoplasms | 1978 |
Immunological responsiveness and adjunct immunotherapy in lung cancer.
Topics: Aged; Animals; Cell Migration Inhibition; Female; Fluorouracil; Humans; Immunotherapy; Lung Neoplasms; Lymphocytes; Male; Mice; Mice, Nude; Middle Aged; Phytohemagglutinins; Picibanil; Tuberculin Test | 1978 |
[Symposium on cancer and immunity. (5) Experimental and clinical evaluation of chemoimmunotherapy for solid tumors (author's transl)].
Topics: Animals; Antineoplastic Agents; BCG Vaccine; Drug Therapy, Combination; Evaluation Studies as Topic; Fluorouracil; Humans; Immunotherapy; Male; Mice; Mitomycins; Neoplasms; Neoplasms, Experimental; Picibanil | 1978 |
[Intra-arterial infusion chemotherapy for recurrent cervical lymph nodes after surgery in esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Peplomycin; Picibanil; Postoperative Period | 1992 |
[The efficacy of transarterial immuno-embolization therapy in patients with hepatocellular carcinoma].
Topics: Administration, Oral; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fibrinogen; Fluorouracil; Hepatic Artery; Humans; Immunotherapy; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Picibanil; Thrombin | 1992 |
[Multimodal treatment for advanced, ovarian cancer patients with poor performance status--its effectiveness and limitations].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Immunotherapy; Middle Aged; Ovarian Neoplasms; Ovariectomy; Picibanil; Prognosis; Survival Rate | 1992 |
A case of linitis plastica of the rectum treated by pelvic exenteration after aggressive immunochemotherapy.
Topics: Adult; Combined Modality Therapy; Fluorouracil; Humans; Infusions, Intra-Arterial; Injections, Intradermal; Injections, Intralesional; Linitis Plastica; Male; Methotrexate; Pelvic Exenteration; Picibanil; Rectal Neoplasms | 1992 |
[Evaluation of loco-regional cancer chemotherapy with assistance of home parenteral nutrition].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged; Parenteral Nutrition, Home Total; Picibanil; Stomach Neoplasms; Survival Rate | 1992 |
Promotion of hepatic metastases by liver resection in the rat.
Topics: Animals; Fluorouracil; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Liver Regeneration; Mitomycin; Neoplasm Metastasis; Picibanil; Rats; Rats, Inbred Strains | 1992 |
[Regional immunochemotherapy for liver metastasis of esophageal cancer in a patient with variant hepatic artery].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps; Infusions, Intra-Arterial; Injections, Intramuscular; Liver Neoplasms; Male; Middle Aged; Picibanil; Tegafur; Uracil | 1991 |
[Intraperitoneal chemotherapy through implantable injection port in patients with advanced ovarian (or tubal) carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Fallopian Tube Neoplasms; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Picibanil | 1991 |
[Intraperitoneal administration of cis-platin with arterial infusion chemotherapy of advanced and recurrent gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms | 1991 |
[A case of unresectable liver metastasis from leiomyosarcoma of the stomach successfully treated by intra hepato-arterial chemotherapy with Infuse-A-Port].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leiomyosarcoma; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms | 1990 |
[Evaluation of ACNU and 5-FU in the treatment of gliomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biological Products; Brain Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Glioblastoma; Humans; Male; Nimustine; Nitrosourea Compounds; Picibanil | 1986 |
Effect of immunostimulants and antitumor agents on tumor necrosis factor (TNF) production.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Drug Interactions; Fluorouracil; Male; Mice; Mice, Inbred C57BL; Picibanil; Proteoglycans; Tumor Necrosis Factor-alpha | 1987 |
[Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Products; Biotransformation; Colonic Neoplasms; Fluorouracil; Humans; Lymphatic Metastasis; Picibanil; Stomach Neoplasms; Tegafur; Tissue Distribution; Uracil | 1989 |
[Three cases of effective hepatic arterial infusion with OK-432, mitomycin C and 5-fluorouracil in liver metastasis from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Remission Induction; Stomach Neoplasms | 1989 |
[Combination therapy of hyperthermia and other methods in liver and bile tract cancers--evaluation of these methods using cancer cell lines in vitro].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Combined Modality Therapy; Doxorubicin; Fluorouracil; Gallbladder Neoplasms; Humans; Hyperthermia, Induced; In Vitro Techniques; Liver Neoplasms; Mitomycin; Mitomycins; Picibanil; Tumor Necrosis Factor-alpha | 1989 |
[A long-survival case of hepatocellular carcinoma treated by intra-arterial chemotherapy and immunotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carcinoma, Hepatocellular; Combined Modality Therapy; Doxorubicin; Fluorouracil; Humans; Infusions, Intra-Arterial; Injections; Injections, Intradermal; Liver Neoplasms; Male; Picibanil; Remission Induction | 1989 |
[Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Immunization, Passive; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasms, Experimental; Organoplatinum Compounds; Picibanil; Transplantation, Autologous | 1989 |
[Synchronous double cancers in the ovary and kidney--a case report].
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Kidney Neoplasms; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Peptichemio; Picibanil; Postoperative Care | 1988 |
[A case of abdominal wall fistula due to cholangioma].
Topics: Abdominal Muscles; Adenoma, Bile Duct; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Combined Modality Therapy; Female; Fistula; Fluorouracil; Humans; Infusions, Intra-Arterial; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis | 1985 |
[Surgery and adjuvant therapy of cancer of the large intestine].
Topics: BCG Vaccine; Colonic Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Fluorouracil; Humans; Intraoperative Period; Mitomycin; Mitomycins; Picibanil; Postoperative Period; Proteoglycans; Radiotherapy Dosage; Rectal Neoplasms | 1986 |
[Influence of OK-432 on the concentration of active substance of fluoropyrimidine carcinostatics in the living body].
Topics: Biological Products; Fluorouracil; Head and Neck Neoplasms; Humans; Picibanil; Tegafur | 1986 |
[Improved quality of life in a patient with Borrmann type 4 gastric cancer treated with combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Effects of OK-432 on UFT activation].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Fluorouracil; Humans; Liver Neoplasms, Experimental; Male; Middle Aged; Neoplasms; Picibanil; Rats; Rats, Inbred Strains; Tegafur; Uracil | 1988 |
[MQF-FT and MQF-UFT in gallbladder and bile duct cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carbazilquinone; Drug Administration Schedule; Female; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Tegafur; Uracil | 1988 |
[Clinical studies of the treatment of bladder tumor and its effects--experience in 86 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis; Tegafur; Uracil; Urinary Bladder Neoplasms | 1988 |
[Local treatment of locally recurrent breast cancers].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Breast Neoplasms; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Middle Aged; Neoplasm Recurrence, Local; Picibanil; Proteoglycans | 1988 |
[A case report of the effective arterial infusion for advanced recurrence breast cancer with 5-FU, ADM, CDDP and OK-432].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Lymph Node Excision; Mastectomy; Picibanil | 1988 |
[The significance of endoscopic treatment of early gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Gastroscopy; Humans; Male; Middle Aged; Mitomycins; Picibanil; Stomach Neoplasms | 1988 |
[Influence of immunopotentiators on the activation of 5-FU derivatives].
Topics: Adjuvants, Immunologic; Animals; Biological Products; Cytochrome P-450 Enzyme System; Fluorouracil; In Vitro Techniques; Male; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Picibanil; Proteoglycans; Rats; Rats, Inbred Strains; Tegafur | 1985 |
[Preoperative combination therapy involving local administration of a non-specific immunoactivated preparation (OK-432) and chemotherapeutic preparations for patients with stomach cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Preoperative Care; Stomach Neoplasms | 1985 |
[Preoperative cancer chemotherapy for gastric cancer].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Lymphatic Metastasis; Methotrexate; Mitomycin; Mitomycins; Picibanil; Preoperative Care; Stomach Neoplasms | 1985 |
[Thermotherapy for cancer of the urinary bladder in combination with tegafur suppository and picibanil--concentrations of tegafur in the serum and tissues in bladder carcinoma].
Topics: Adult; Aged; Biological Products; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Fluorouracil; Humans; Hyperthermia, Induced; Male; Middle Aged; Picibanil; Suppositories; Tegafur; Urinary Bladder; Urinary Bladder Neoplasms | 1985 |
[A case of advanced gastric cancer showing complete cure by immunochemotherapy with FT-207 and OK-432 confirmed by thorough histologic examination of total gastrectomy matter].
Topics: Adenocarcinoma; Biological Products; Female; Fluorouracil; Gastrectomy; Humans; Injections, Intradermal; Middle Aged; Picibanil; Stomach; Stomach Neoplasms; Suppositories; Tegafur | 1985 |
Immunochemosurgery for gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modality Therapy; Cytarabine; Fluorouracil; Gastrectomy; Humans; Immunocompetence; Mitomycin; Mitomycins; Neoplasm Staging; Picibanil; Prognosis; Stomach Neoplasms | 1985 |
[Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fluorouracil; Hepatic Artery; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis | 1984 |
[Combination chemotherapy of brain tumors with ACNU and 5-FU].
Topics: Astrocytoma; Biological Products; Brain Neoplasms; Combined Modality Therapy; Drug Therapy, Combination; Ependymoma; Fluorouracil; Glioma; Humans; Lymphoma; Meningeal Neoplasms; Meningioma; Nimustine; Nitrosourea Compounds; Oligodendroglioma; Picibanil | 1983 |
[Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan)].
Topics: Animals; Cell Division; Cell Line; Female; Fluorouracil; Interferon Inducers; Interferons; Lentinan; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Picibanil; Poly I-C | 1984 |
[Combination chemotherapy with neocarzinostatin (NCS) and other antitumor agents for advanced carcinoma of the digestive organs--improved clinical effect with NFO therapy].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Picibanil; Zinostatin | 1982 |
[Combination chemotherapy with neocarzinostatin(NCS), HCFU and picibanil(NHO therapy) for advanced carcinoma of the digestive system--a comparative study with NF, and NFO therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Digestive System Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Picibanil; Zinostatin | 1984 |
[Nonspecific cell-mediated immunity of gynecologic cancer patients and related effects of chemotherapy and immunotherapy].
Topics: Female; Fluorouracil; Humans; Immunity, Cellular; Leukocyte Count; Mitomycin; Mitomycins; Ovarian Neoplasms; Picibanil; Rosette Formation; T-Lymphocytes; Uterine Neoplasms | 1983 |
[Chemotherapy of unresectable Borrmann's type IV stomach cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms; Tegafur | 1983 |
[Preoperative immunochemotherapy for gastric cancer combined with perifocal administration of OK-432].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Preoperative Care; Stomach Neoplasms | 1984 |
[Chemotherapy of unresectable Borrmann type 4 gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Combinations; Fluorouracil; Humans; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1984 |
[Thermotherapy for cancer of the urinary bladder in combination with tegafur and picibanil--with special reference to the serum bladder and bladder cancer tissue concentrations of tegafur in a perfusion fluid].
Topics: Aged; Biological Products; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hyperthermia, Induced; Male; Middle Aged; Picibanil; Tegafur; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
[MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cytarabine; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms | 1982 |
[Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
Topics: Aged; Animals; Antibiotics, Antineoplastic; Biological Products; Carcinoma, Ehrlich Tumor; Drug Therapy, Combination; Female; Fluorouracil; Humans; Injections; Male; Mice; Middle Aged; Mitomycin; Mitomycins; Picibanil; Preoperative Care; Stomach Neoplasms | 1982 |
[Preoperative OMF therapy for gastric cancer--examination of macroscopical effect in comparison with histological effect].
Topics: Adult; Aged; Biological Products; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Preoperative Care; Stomach; Stomach Neoplasms | 1982 |
[Effects of protein calorie intake on immuno- and chemotherapy].
Topics: Animals; Dietary Proteins; Female; Fluorouracil; Killer Cells, Natural; Lentinan; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Picibanil; Protein-Energy Malnutrition | 1982 |
[Clinical evaluation of immunochemotheray on advanced gastric cancer--combination of OK-432 (picibanil), mitomycin C, and 5-fluorouracil (MF-O therapy) (author's transl)].
Topics: Biological Products; Drug Therapy, Combination; Fluorouracil; Humans; Immunotherapy; Mitomycins; Neoplasm Staging; Picibanil; Stomach Neoplasms | 1980 |
[Two cases of hepatic metastasis of colorectal cancer treated effectively by intrahepatic arterial infusion immunotherapy using OK-432, rIL-2, MMC and 5-FU].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Immunotherapy; Infusions, Intra-Arterial; Interleukin-2; Liver Neoplasms; Male; Middle Aged; Mitomycin; Picibanil; Recombinant Proteins | 1994 |
[Complete response in a case of unresectable gastric cancer treated by combined chemoimmunotherapy of MMC, 5-FU and OK-432].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Mitomycin; Picibanil; Remission Induction; Stomach Neoplasms | 1994 |
[Tissue and serum levels of 5-FU in the patients with head and neck malignant tumors--influence of a streptococcal preparation OK-432].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunotherapy; Lymphatic Metastasis; Male; Middle Aged; Picibanil; Tegafur; Uracil | 1993 |
[Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytokines; Doxorubicin; Fluorouracil; Humans; Immunotherapy; Injections, Intralesional; Interleukin-2; Killer Cells, Natural; Liver Neoplasms; Mitomycin; Picibanil; Stomach Neoplasms | 1993 |
[Transarterial immuno-chemotherapy including adoptive transfer of autologous cultured lymphocytes for stage IV breast cancer patients with locally-advanced tumor].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Immunotherapy, Adoptive; Infusions, Intra-Arterial; Lymphocytes, Tumor-Infiltrating; Middle Aged; Picibanil; Subclavian Artery | 1993 |
Differential chemosensitivity of local and metastatic human gastric cancer after orthotopic transplantation of histologically intact tumor tissue in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Combined Modality Therapy; Disease Models, Animal; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Immunotherapy; Killer Cells, Natural; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Picibanil; Spleen; Stomach Neoplasms; Transplantation, Heterologous | 1993 |
[A case of advanced gastric cancer responding to chemotherapy and radiotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Ethanol; Fluorouracil; Gastrectomy; Humans; Injections, Intralesional; Liver Neoplasms; Male; Picibanil; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[Locoregional therapy for liver metastases of colorectal cancer].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Doxorubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Interleukin-2; Leucovorin; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Middle Aged; Picibanil; Rabbits | 1996 |
Synergistic effects of Actinobacillus suis cells in combination with 5-fluorouracil on mice bearing murine L1210 leukemia cells.
Topics: Actinobacillus; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Combined Modality Therapy; Female; Fluorouracil; Immunization; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mycobacterium bovis; Neoplasm Transplantation; Picibanil; Survival Rate; Tumor Cells, Cultured | 1997 |
[Seven patients with stage IVb advanced gastric cancer who were treated with preoperative chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Lentinan; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Picibanil; Preoperative Care; Prognosis; Stomach Neoplasms; Survival Analysis | 2000 |
Unresectable advanced gastric cancer effectively treated by combined chemo-immunotherapy: a report of two cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Humans; Immunotherapy; Male; Mitomycin; Picibanil; Radiography; Stomach Neoplasms | 2000 |
Biochemical modulation of 5-fluorouracil with a streptococcal preparation, OK-432, against murine colon-26 carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorodeoxyuridylate; Fluorouracil; Male; Mice; Picibanil; RNA; Thymidine Kinase; Thymidylate Synthase | 2000 |
Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer.
Topics: Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Combined Modality Therapy; Dihydrouracil Dehydrogenase (NADP); DNA Primers; Drug Resistance, Neoplasm; Fluorouracil; Humans; Immunotherapy; Oxidoreductases; Picibanil; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Salivary Gland Neoplasms; Thymidylate Synthase; Tumor Cells, Cultured | 2001 |
[Therapeutic effect of multimodal therapy, such as cryosurgery, locoregional immunotherapy and systemic chemotherapy against far advanced breast cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Cisplatin; Combined Modality Therapy; Cryosurgery; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Immunotherapy; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Picibanil; Taxoids | 2001 |
Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorouracil; Gastrectomy; Humans; Immunotherapy; Lentinan; Life Tables; Male; Middle Aged; Mitomycin; Neoplasm Proteins; Picibanil; Stomach Neoplasms; Survival Analysis; Thymidylate Synthase | 2002 |
Treatment of maxillary sinus carcinoma: clinical results using the Kitasato modality.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Protocols; Carcinoma; Combined Modality Therapy; Female; Fluorouracil; Hospitals, University; Humans; Japan; Male; Maxillary Sinus Neoplasms; Middle Aged; Neoplasm Staging; Otorhinolaryngologic Surgical Procedures; Outcome Assessment, Health Care; Picibanil; Radiotherapy Dosage; Retrospective Studies; Severity of Illness Index; Survival Rate | 2002 |
[Cryoimmunological therapy with local injection of OK-432 against advance or recurrent breast cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cryosurgery; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Injections, Intralesional; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Picibanil; Taxoids | 2003 |
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Combinations; Floxuridine; Fluorouracil; Gastrectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Neoplasm Staging; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 2005 |
[Radiation, 5-FU and OK-432: inhibitory effect of IL-10 and TGF-beta].
Topics: Fluorouracil; Humans; In Vitro Techniques; Interferon-gamma; Interleukin-10; Interleukin-12; Interleukin-18; Intracellular Signaling Peptides and Proteins; Leukocytes, Mononuclear; Picibanil; Repressor Proteins; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2005 |
Immunochemoradiotherapy for patients with oral squamous cell carcinoma: augmentation of OK-432-induced helper T cell 1 response by 5-FU and X-ray irradiation.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cytokines; Dendritic Cells; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Leukocytes, Mononuclear; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Picibanil; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Th1 Cells; Th2 Cells; Transcription Factors | 2013 |
Effects of Liposome-Entrapped Muramyl Tripeptide Phosphatidylethanolamine (L-MTP-PE) on the Tumor Growth and Survival of Mice Bearing Syngeneic Tumor in Combination with a Chemotherapeutic or Immunomodulatory Agent.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Drug Carriers; Fluorouracil; Immunologic Factors; Immunomodulating Agents; Liposomes; Liver Neoplasms; Mice; Phosphatidylethanolamines; Picibanil | 2022 |